β-Amyloid precursor protein is detectable on monocytes and is increased in Alzheimer’s disease
暂无分享,去创建一个
[1] H. Fernández,et al. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part IV: can calpain act as alpha-secretase? , 1998, Frontiers in bioscience : a journal and virtual library.
[2] A. LeBlanc,et al. Protein Kinase C Activation Increases Release of Secreted Amyloid Precursor Protein without Decreasing Aβ Production in Human Primary Neuron Cultures. , 1998, The Journal of Neuroscience.
[3] N. Cashman,et al. Prion protein expression in human leukocyte differentiation. , 1998, Blood.
[4] G. Binetti,et al. Specific role for protein kinase Cα in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts , 1998, Neuroscience Letters.
[5] C. Masters,et al. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.
[6] R. Doms,et al. Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.
[7] Y. Ihara,et al. Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42* , 1997, The Journal of Biological Chemistry.
[8] J. Buxbaum,et al. Increased Secretion of the Amino‐Terminal Fragment of Amyloid Precursor Protein in Brains of Rats with a Constitutive Up‐Regulation of Protein Kinase C , 1997, Journal of neurochemistry.
[9] S. Gauthier,et al. Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging , 1997, Neurobiology of Aging.
[10] J. Nalbantoglu,et al. Alzheimer's beta‐amyloid precursor protein is expressed on the surface of immediately ex vivo brain cells: A flow cytometric study , 1996, Journal of neuroscience research.
[11] M. Alberoni,et al. Erythrocytic calpain-calpastatin system in Alzheimer’s disease , 1996, Aging.
[12] M. Trabucchi,et al. Defective Protein Kinase C α Leads to Impaired Secretion of Soluble β‐Amyloid Precursor Protein from Alzheimer's Disease Fibroblasts a , 1996 .
[13] S. Gauthier,et al. Polymerase chain reaction quantification of lymphoid amyloid precursor protein mRNAs in Alzheimer's disease and Down's syndrome , 1995, Neuroscience Letters.
[14] H. Sorimachi,et al. Conventional protein kinase C (PKC)‐α and novel PKCε, but not ‐δ, increase the secretion of an N‐terminal fragment of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts , 1995 .
[15] E. Ikonen,et al. Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendrites , 1995, Journal of neuroscience research.
[16] S. Grinstein,et al. Signaling events in monocytes and macrophages. , 1995, New horizons.
[17] R. Kalaria,et al. Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease , 1995, Nature Medicine.
[18] C. Masters,et al. Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP) , 1994, FEBS letters.
[19] A. Prochiantz,et al. Amyloid precursor protein in cortical neurons: coexistence of two pools differentially distributed in axons and dendrites and association with cytoskeleton , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] N. Reiner,et al. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. , 1994, Journal of immunology.
[21] K. Suzuki,et al. Processing and secretion of Alzheimer's disease amyloid precursor protein. , 1994, The Tohoku journal of experimental medicine.
[22] K. Beyreuther,et al. Amyloid precursor protein secretion and βA4 amyloid generation are not mutually exclusive , 1994, FEBS letters.
[23] C. Masters,et al. The βA4 amyloid precursor protein binding to copper , 1994 .
[24] R. Scott,et al. Alzheimer's disease and down syndrome: leukocyte membrane fluidity alterations , 1994, Mechanisms of Ageing and Development.
[25] S. Squazzo,et al. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.
[26] R. Tanzi,et al. Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.
[27] R. Tanzi,et al. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). , 1994, The Journal of biological chemistry.
[28] K. Beyreuther,et al. Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. , 1993, The Journal of biological chemistry.
[29] F. Lund-Johansen,et al. Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphosphatidelinositol‐anchored antigens , 1993, European journal of immunology.
[30] Raymond,et al. Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. , 1993, The Journal of clinical investigation.
[31] J. Trojanowski,et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Growdon,et al. Receptor‐coupled Amyloid Precursor Protein Processing a , 1993, Annals of the New York Academy of Sciences.
[34] C. Masters,et al. A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. , 1993, The Journal of biological chemistry.
[35] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[36] R. Sékaly,et al. Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. , 1993, Journal of immunology.
[37] P. McGuffin,et al. Amyloid precursor protein mRNA levels in the mononuclear blood cells of Alzheimer's and Down's patients. , 1993, Brain research. Molecular brain research.
[38] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[39] B. Strooper,et al. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway , 1993, The Journal of cell biology.
[40] I. Nishimoto,et al. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go , 1993, Nature.
[41] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[42] S. Sisodia. Secretion of the β‐Amyloid Precursor Protein a , 1992 .
[43] A. Schmaier,et al. Potential Role of Protease Nexin‐2/Amyloid β‐Protein Precursor as a Cerebral Anticoagulant a , 1992 .
[44] J. Shioi,et al. Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells , 1992, Journal of neuroscience research.
[45] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[46] D. Selkoe,et al. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.
[47] S. Younkin,et al. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. , 1992, Science.
[48] D. Selkoe,et al. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.
[49] L. Refolo,et al. The Alzheimer amyloid precursor is associated with the detergent- insoluble cytoskeleton , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[50] R. Cotter,et al. Secretion of the β/A4 amyloid precursor protein: Identification of a cleavage site in cultured mammalian cells , 1991 .
[51] D. Selkoe,et al. Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease. , 1990, Biochemical and biophysical research communications.
[52] S. Wagner,et al. Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor. , 1990, The Journal of biological chemistry.
[53] T. Oltersdorf,et al. Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.
[54] Neil R. Cashman,et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation , 1990, Cell.
[55] R. Neve,et al. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. , 1990, The Journal of biological chemistry.
[56] F. Coffman,et al. Aging and deffective lymphoid cell activation , 1989, Experimental Gerontology.
[57] G. Cole,et al. The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion , 1989, Neuron.
[58] D. Selkoe,et al. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.
[59] Andreas Weidemann,et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.
[60] G. Eisenbarth,et al. Trisomy 21 (Down's syndrome): autoimmunity, aging and monoclonal antibody-defined T-cell abnormalities. , 1989, Journal of autoimmunity.
[61] D. Selkoe,et al. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[62] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[63] F. R. Brown,et al. Immunologic dysfunction: simultaneous study of alzheimer's and older down's patients , 1987, Mechanisms of Ageing and Development.
[64] D. Luchins,et al. Senile dementia of Alzheimer's type (SDAT) , 1985, Neurology.
[65] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[66] R. Walford. Immunological Studies of Down's Syndrome and Alzheimer's Disease * , 1982, Annals of the New York Academy of Sciences.
[67] R. Ebstein,et al. Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease. , 1996, Brain research. Molecular brain research.
[68] B. Greenberg,et al. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[69] G. Multhaup. Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans. , 1994, Biochimie.
[70] A. Burns. Clinical diagnosis of Alzheimer's disease , 1991 .
[71] Schweber Ms,et al. Alzheimer's disease and Down syndrome. , 1989, Progress in clinical and biological research.